Supplementary Figure S2 from Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non–Small Cell Lung Cancer

Read full text
Authors: Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal, J.L. González-Larriba, Alex Martínez‐Martí, Reyes Bernabé, Joaquim Bosch‐Barrera, Virginia Calvo, Amelia Insa Molla, Noemí Reguart, Javier de Castro, Carlos Aguado
+10 more Ramón Palmero, Florentino Hernándo, Javier Martín-López, Alejandro Rodríguez-Festa, Pilar Mediavilla-Medel, Martín Lázaro, Jim Hayes, Alberto Cruz‐Bermúdez, Bartomeu Massutí, Atocha Romero
Cited by: 0

Abstract

Supplementary Figure 2. Kaplan–Meier curves for event-free survival (EFS) and overall survival (OS) according to minimal residual disease (MRD) status. (A) EFS in the experimental arm. (B) OS in the experimental arm. (C) EFS in the control arm. (D) OS in the control arm. MRD positivity was defined as MRD detection at any time point. Hazard ratios (HR) with 95% confidence intervals were estimated using Cox proportional hazards models, and P values were calculated with the log-rank test.

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations Lung Cancer Research Studies

Publication details

Publication date
17 February 2026
Language
EN